{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:06:09Z","timestamp":1788980769363,"version":"build-2803163510"},"reference-count":45,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Med Inform"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preoperative stratification for non\u2013small cell lung cancer (NSCLC) necessitates separate evaluations of lymph node metastasis (LNM) to guide surgical decisions and of programmed death-ligand 1 (PD-L1) expression to inform immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to develop and validate an integrated diagnostic solution that could simultaneously predict both LNM status and PD-L1 expression status from a single, standard-of-care\n                      <jats:sup>18<\/jats:sup>\n                      F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT) scan.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this multicenter study, we segmented primary tumors and peritumoral 15-mm expansion regions from preoperative PET\/CT scans of 273 patients (for LNM prediction) and 242 patients (for PD-L1 prediction). A total of 7868 radiomic features from intratumoral and peritumoral regions were extracted. Following rigorous feature selection, 2 independent models were developed using machine learning and tested on a temporal validation cohort (n=45). Model performance was benchmarked against clinicopathological models and nuclear medicine physicians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The integrated model for LNM prediction (PT-IPT-LR) achieved an area under the curve of 0.845 (95% CI 0.716\u20100.973) in the temporal validation cohort, with a sensitivity of 0.765 (95% CI 0.518\u20101.000) and a specificity of 0.786 (95% CI 0.602\u20100.970). The model for PD-L1 expression (PT-IPT-SVM) achieved an area under the curve of 0.776 (95% CI 0.641\u20100.911) in the temporal validation cohort, with a sensitivity of 0.800 (95% CI 0.609\u20100.991) and a specificity of 0.650 (95% CI 0.401\u20100.899). Decision curve analysis confirmed the clinical utility of both models. Critically, we found no significant correlation between the radiomic signatures of LNM and PD-L1, which validates our 2-model approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We present a radiomics framework that noninvasively integrates prediction of LNM and PD-L1 from a single preoperative PET\/CT scan. This tool may enable preoperative stratification, potentially optimizing both surgical and systemic treatment planning for patients with NSCLC in a single step.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/86835","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:11:50Z","timestamp":1788977510000},"page":"e86835-e86835","source":"Crossref","is-referenced-by-count":0,"title":["Integrating Lymph Node Metastasis and Programmed Death-Ligand 1 Prediction in Non\u2013Small Cell Lung Cancer From a Single PET\/CT Scan: Multicenter Radiomics Study"],"prefix":"10.2196","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8013-0478","authenticated-orcid":false,"given":"Wen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2044-3891","authenticated-orcid":false,"given":"Qiufang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7093-1981","authenticated-orcid":false,"given":"Huiling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-1805","authenticated-orcid":false,"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1439-6062","authenticated-orcid":false,"given":"Zhihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-1724","authenticated-orcid":false,"given":"Silong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-7522","authenticated-orcid":false,"given":"Shaoli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"1","key":"R1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"R2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1200\/JCO.21.01881","article-title":"Extensive-stage small-cell lung cancer: first-line and second-line treatment options","volume":"40","author":"Zugazagoitia","journal-title":"J Clin Oncol"},{"issue":"5","key":"R3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non-small cell lung cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Ettinger","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"R4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jtho.2023.09.1443","article-title":"A shift in paradigm: selective lymph node dissection for minimizing oversurgery in early stage lung cancer","volume":"19","author":"Jiang","journal-title":"J Thorac Oncol"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-025-03559-3","article-title":"Predictors of occult lymph node metastasis in clinical T1 lung adenocarcinoma: a retrospective dual-center study","volume":"25","author":"Huang","journal-title":"BMC Pulm Med"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03345-7","article-title":"Machine learning predictive models and risk factors for lymph node metastasis in non-small cell lung cancer","volume":"24","author":"Wu","journal-title":"BMC Pulm Med"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-024-01300-w","article-title":"A deep learning-based radiomics model for predicting lymph node status from lung adenocarcinoma","volume":"24","author":"Xie","journal-title":"BMC Med Imaging"},{"issue":"5","key":"R8","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.athoracsur.2004.11.025","article-title":"Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer","volume":"79","author":"Watanabe","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1148\/radiol.2021210902","article-title":"Deep learning for prediction of N2 metastasis and survival for clinical stage I non-small cell lung cancer","volume":"302","author":"Zhong","journal-title":"Radiology"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42811-4","article-title":"PET\/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer","volume":"14","author":"Zhong","journal-title":"Nat Commun"},{"issue":"6230","key":"R11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","journal-title":"Science"},{"issue":"10066","key":"R12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","journal-title":"Lancet"},{"issue":"6","key":"R13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41568-024-00694-7","article-title":"A guide to artificial intelligence for cancer researchers","volume":"24","author":"Perez-Lopez","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-00977-4","article-title":"The predictive value of [F]FDG PET\/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma","volume":"13","author":"Gao","journal-title":"EJNMMI Res"},{"issue":"3","key":"R15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.21037\/tlcr.2020.04.17","article-title":"Predicting EGFR mutation subtypes in lung adenocarcinoma using F-FDG PET\/CT radiomic features","volume":"9","author":"Liu","journal-title":"Transl Lung Cancer Res"},{"issue":"12","key":"R16","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1007\/s00330-016-4292-8","article-title":"The diagnostic ability of F-FDG PET\/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer","volume":"26","author":"Lee","journal-title":"Eur Radiol"},{"issue":"8","key":"R17","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1007\/s00330-020-07624-9","article-title":"A PET\/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer","volume":"31","author":"Xie","journal-title":"Eur Radiol"},{"issue":"9","key":"R18","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00259-019-04348-x","article-title":"F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer","volume":"46","author":"Jreige","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"R19","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00262-020-02560-5","article-title":"F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer","volume":"69","author":"Mitchell","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"R20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00259-019-04500-7","article-title":"New insight on the correlation of metabolic status on F-FDG PET\/CT with immune marker expression in patients with non-small cell lung cancer","volume":"47","author":"Wang","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"R21","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1007\/s00330-024-10651-5","article-title":"Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([F]FDG) positron emission tomography\/computed tomography (PET\/CT) metabolic parameters in resectable non-small cell lung cancer","volume":"34","author":"Hughes","journal-title":"Eur Radiol"},{"issue":"2","key":"R22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00330-022-09109-3","article-title":"Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer","volume":"33","author":"Chen","journal-title":"Eur Radiol"},{"issue":"5","key":"R23","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1016\/j.crad.2023.02.004","article-title":"Radiomics nomogram integrating intratumoural and peritumoural features to predict lymph node metastasis and prognosis in clinical stage IA non-small cell lung cancer: a two-centre study","volume":"78","author":"Chen","journal-title":"Clin Radiol"},{"issue":"11","key":"R24","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jtho.2016.06.006","article-title":"Clinical significance of PD-L1 protein expression in surgically resected primary lung adenocarcinoma","volume":"11","author":"Takada","journal-title":"J Thorac Oncol"},{"issue":"1","key":"R25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67239-8","article-title":"Mitigating the impact of image processing variations on tumour [18F]-FDG-PET radiomic feature robustness","volume":"14","author":"Ramlee","journal-title":"Sci Rep"},{"issue":"3","key":"R26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00259-021-05480-3","article-title":"F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma","volume":"49","author":"Eertink","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"R27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","journal-title":"J Chiropr Med"},{"issue":"3","key":"R28","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/S2589-7500(20)30002-9","article-title":"CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction","volume":"2","author":"Vaidya","journal-title":"Lancet Digit Health"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.11.017","article-title":"Preoperative CT-based peritumoral and tumoral radiomic features prediction for tumor spread through air spaces in clinical stage I lung adenocarcinoma","volume":"163","author":"Liao","journal-title":"Lung Cancer"},{"issue":"6","key":"R30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41416-025-02948-z","article-title":"Intratumoral and peritumoral PET\/CT-based radiomics for non-invasively and dynamically predicting immunotherapy response in NSCLC","volume":"132","author":"Lin","journal-title":"Br J Cancer"},{"issue":"1","key":"R31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00259-021-05509-7","article-title":"Current status and quality of radiomic studies for predicting immunotherapy response and outcome in patients with non-small cell lung cancer: a systematic review and meta-analysis","volume":"49","author":"Chen","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"21","key":"R32","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","journal-title":"Cancer Res"},{"issue":"2","key":"R33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The Image Biomarker Standardization Initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","journal-title":"Radiology"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.3389\/fradi.2023.1153784","article-title":"uRP: an integrated research platform for one-stop analysis of medical images","volume":"3","author":"Wu","journal-title":"Front Radiol"},{"issue":"9","key":"R35","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.ultrasmedbio.2022.04.217","article-title":"Prediction model and nomogram of early recurrence of hepatocellular carcinoma after radiofrequency ablation based on logistic regression analysis","volume":"48","author":"Ni","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"R36","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-022-01605-z","article-title":"Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter","volume":"22","author":"Fang","journal-title":"BMC Surg"},{"issue":"9","key":"R37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239281","article-title":"Risk factors of lobar lymph node metastases in non-primary tumor-bearing lobes among the patients of non-small-cell lung cancer","volume":"15","author":"Liu","journal-title":"PLOS One"},{"issue":"16","key":"R38","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/jnci\/djt166","article-title":"Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller","volume":"105","author":"Nitadori","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"R39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/ejcts\/ezv485","article-title":"Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller","volume":"50","author":"Hung","journal-title":"Eur J Cardiothorac Surg"},{"issue":"8","key":"R40","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/JTO.0b013e31825871de","article-title":"Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients","volume":"7","author":"Koike","journal-title":"J Thorac Oncol"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2016.12.006","article-title":"The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma","volume":"104","author":"Takada","journal-title":"Lung Cancer"},{"issue":"1","key":"R42","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01497-6","article-title":"Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer","volume":"28","author":"Ren","journal-title":"Eur J Med Res"},{"issue":"1","key":"R43","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-00956-9","article-title":"Predicting PD-L1 expression status in patients with non-small cell lung cancer using [F]FDG PET\/CT radiomics","volume":"13","author":"Zhao","journal-title":"EJNMMI Res"},{"issue":"10","key":"R44","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00259-022-05783-z","article-title":"The \u201cdigital biopsy\u201d in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET\/CT","volume":"49","author":"Monaco","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R45","unstructured":"sophiachen997\/peritumoral-prediction. GitHub. URL: https:\/\/github.com\/sophiachen997\/Peritumoral-prediction [Accessed 29-07-2026]"}],"container-title":["JMIR Medical Informatics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:11:53Z","timestamp":1788977513000},"score":1,"resource":{"primary":{"URL":"https:\/\/medinform.jmir.org\/2026\/1\/e86835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":45,"URL":"https:\/\/doi.org\/10.2196\/86835","relation":{},"ISSN":["2291-9694"],"issn-type":[{"value":"2291-9694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"article-number":"v14i1e86835"}}